3M Company (MMM) - 2005 Form 10-K Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 2005. 3M is a diversified global technology company operating in seven segments: Health Care, Industrial, Display and Graphics, Consumer and Office, Electro and Communications, Safety, Security and Protection Services, and Transportation. The company employs approximately 69,315 people globally. In 2005, 3M completed the acquisition of CUNO, Incorporated, a filtration products company, for approximately $1.36 billion. Effective January 1, 2006, the Industrial and Transportation segments were combined.
Key Financial Metrics
| Metric | 2005 | 2004 |
|---|---|---|
| Net Sales | $21,167 million | $20,011 million |
| Operating Income | $5,009 million | $4,578 million |
| Net Income | $3,199 million | $2,990 million |
| Diluted EPS | $4.12 | $3.75 |
| Operating Margin | 23.7% | 22.9% |
| Operating Cash Flow | $4,258 million | $4,282 million |
| Total Debt | $2,381 million | $2,821 million |
| Cash & Equivalents | $1,072 million | $2,757 million |
| Debt-to-Capital Ratio | 19% | 21% |
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 5.8% year-over-year, driven by core local-currency sales growth of 4.1% and the CUNO acquisition (which added 1.0% to sales). All seven business segments reported positive local-currency sales growth.
- Profitability: Operating income rose 9.4% to $5.009 billion. The operating margin expanded to 23.7%, aided by improved selling prices, favorable product mix, and productivity gains that offset a 6.0% increase in raw material costs.
- Acquisitions: The acquisition of CUNO in August 2005 added significant filtration capabilities to the Industrial segment. Smaller acquisitions included assets from Siemens Ultrasound and Mercury Online Solutions.
- Shareholder Returns: The company returned $3.6 billion to shareholders in 2005 through dividends ($1.286 billion) and stock repurchases ($2.3 billion). The quarterly dividend was increased by 16.7% to $0.42 per share.
- Accounting Changes: Net income was reduced by $110 million due to two items: a $75 million tax charge related to the repatriation of foreign earnings under the American Jobs Creation Act of 2004, and a $35 million after-tax charge from the adoption of FASB Interpretation No. 47 (asset retirement obligations).
Guidance, Outlook, and Risks
- 2006 Outlook: Management expects solid sales growth across the majority of the portfolio, driven by investments in commercialization and emerging markets (Asia, Eastern Europe). Capital expenditures are expected to rise to approximately $1.1 billion in 2006.
- Segment Specifics:
- Health Care: Continued growth expected in core medical/dental businesses, but declines anticipated in personal care and branded pharmaceuticals (specifically Metrogel-Vaginal and Aldara).
- Display and Graphics: Declines in CRT rear projection lens sales expected to persist in the first half of 2006 but be offset by strong growth in LCD display enhancement films.
- Risks and Contingencies:
- Legal Proceedings: Significant exposure remains in respirator mask/asbestos litigation (approx. 48,600 pending claims) and antitrust litigation regarding transparent tape (LePage's Inc. follow-on actions). The company has accrued $210 million for respirator/asbestos liabilities and $7 million for breast implant liabilities.
- Raw Materials: Continued price increases and supply limitations for oil-derived raw materials are expected to carry into 2006.
- Environmental: Ongoing regulatory reviews regarding perfluorooctanyl compounds (PFOA/PFOS) and remediation costs at various sites.
Investor Verification Checklist
- Legal Reserves: Verify the adequacy of the $210 million reserve for respirator/asbestos liabilities given the volume of pending claims and potential legislative changes regarding asbestos reform.
- Pharmaceutical Performance: Monitor the sales trajectory of Aldara and Metrogel-Vaginal, as management explicitly forecasts declines in these branded pharmaceutical products.
- Raw Material Hedging: Assess the effectiveness of 3M's hedging strategies and pricing power in maintaining margins amidst rising oil and natural gas derivative costs.
- Stock-Based Compensation: Note the adoption of SFAS No. 123(R) effective January 1, 2006, which will require expensing stock-based compensation, estimated to impact 2006 diluted EPS by approximately $0.16.
- Segment Reclassification: Be aware that segment reporting will change in 2006 with the combination of Industrial and Transportation segments and the transfer of the Personal Care Division.